Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Influence of diet supplementation with green tea extract on drug-metabolizing enzymes in a mouse model of monosodium glutamate-induced obesity

I. Boušová, P. Matoušková, H. Bártíková, B. Szotáková, V. Hanušová, V. Tománková, E. Anzenbacherová, B. Lišková, P. Anzenbacher, L. Skálová,

. 2016 ; 55 (1) : 361-71. [pub] 20150208

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17001202
E-zdroje Online Plný text

NLK ProQuest Central od 1999-01-01 do 2017-12-31
CINAHL Plus with Full Text (EBSCOhost) od 2006-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1999-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 1999-01-01 do 2017-12-31
Health & Medicine (ProQuest) od 1999-01-01 do 2017-12-31
Family Health Database (ProQuest) od 1999-01-01 do 2017-12-31
Public Health Database (ProQuest) od 1999-01-01 do 2017-12-31

Odkazy

PubMed 25663641
DOI 10.1007/s00394-015-0856-7
Knihovny.cz E-zdroje

PURPOSE: Consumption of dietary supplements with green tea extract (GTE) is popular for weight management, but it may be accompanied by various side effects, including interactions with drugs. The aim of the present in vivo study was to evaluate the effect of defined GTE (Polyphenon 60) in three dosage schemes on insulin, leptin and drug-metabolizing enzymes in obese mice. METHODS: Experimental obesity was induced by repeated s.c. application of monosodium glutamate to newborn mice. Green tea extract was administered in three dosage schemes in chow diet. The plasmatic levels of insulin and leptin were assayed using enzyme-linked immunosorbent assay. Enzyme activities and mRNA expressions of drug-metabolizing enzymes (totally 13) were analyzed in liver and small intestine using spectrophotometric and HPLC assays and RT-PCR, respectively. RESULTS: GTE-treatment decreased insulin and leptin levels. Eleven enzymes were significantly affected by GTE-treatment. Long-term administration of 0.01% GTE caused increase in the activity and mRNA level of cytochrome P450 3A4 (CYP3A4) ortholog in the liver as well as in the small intestine. Interestingly, short-term overdose by GTE (0.1%) had more pronounced effects on enzyme activities and mRNA expressions than long-term overdose. CONCLUSIONS: GTE-mediated induction of CYP3A4 ortholog, the main drug-metabolizing enzyme, could result in decreased efficacy of simultaneously or subsequently administered drug in obese individuals.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17001202
003      
CZ-PrNML
005      
20180525110022.0
007      
ta
008      
170103s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00394-015-0856-7 $2 doi
024    7_
$a 10.1007/s00394-015-0856-7 $2 doi
035    __
$a (PubMed)25663641
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Boušová, Iva $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic. Iva.Bousova@faf.cuni.cz.
245    10
$a Influence of diet supplementation with green tea extract on drug-metabolizing enzymes in a mouse model of monosodium glutamate-induced obesity / $c I. Boušová, P. Matoušková, H. Bártíková, B. Szotáková, V. Hanušová, V. Tománková, E. Anzenbacherová, B. Lišková, P. Anzenbacher, L. Skálová,
520    9_
$a PURPOSE: Consumption of dietary supplements with green tea extract (GTE) is popular for weight management, but it may be accompanied by various side effects, including interactions with drugs. The aim of the present in vivo study was to evaluate the effect of defined GTE (Polyphenon 60) in three dosage schemes on insulin, leptin and drug-metabolizing enzymes in obese mice. METHODS: Experimental obesity was induced by repeated s.c. application of monosodium glutamate to newborn mice. Green tea extract was administered in three dosage schemes in chow diet. The plasmatic levels of insulin and leptin were assayed using enzyme-linked immunosorbent assay. Enzyme activities and mRNA expressions of drug-metabolizing enzymes (totally 13) were analyzed in liver and small intestine using spectrophotometric and HPLC assays and RT-PCR, respectively. RESULTS: GTE-treatment decreased insulin and leptin levels. Eleven enzymes were significantly affected by GTE-treatment. Long-term administration of 0.01% GTE caused increase in the activity and mRNA level of cytochrome P450 3A4 (CYP3A4) ortholog in the liver as well as in the small intestine. Interestingly, short-term overdose by GTE (0.1%) had more pronounced effects on enzyme activities and mRNA expressions than long-term overdose. CONCLUSIONS: GTE-mediated induction of CYP3A4 ortholog, the main drug-metabolizing enzyme, could result in decreased efficacy of simultaneously or subsequently administered drug in obese individuals.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a aromatické hydroxylasy $x genetika $x metabolismus $7 D001189
650    _2
$a cytochrom P-450 CYP2E1 $x genetika $x metabolismus $7 D019392
650    _2
$a cytochrom P-450 CYP3A $x genetika $x metabolismus $7 D051544
650    12
$a potravní doplňky $7 D019587
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a ELISA $7 D004797
650    _2
$a inzulin $x krev $7 D007328
650    _2
$a leptin $x krev $7 D020738
650    _2
$a játra $x účinky léků $x metabolismus $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši obézní $7 D008820
650    _2
$a obezita $x chemicky indukované $x farmakoterapie $7 D009765
650    _2
$a rostlinné extrakty $x farmakologie $7 D010936
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a glutamát sodný $x škodlivé účinky $7 D012970
650    _2
$a čaj $x chemie $7 D013662
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Matoušková, Petra $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic.
700    1_
$a Bártíková, Hana $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic.
700    1_
$a Szotáková, Barbora $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic.
700    1_
$a Hanušová, Veronika $u Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38, Hradec Králové, Czech Republic.
700    1_
$a Tománková, Veronika $u Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic. $7 xx0224707
700    1_
$a Anzenbacherová, Eva $u Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic. $7 stk2008428613
700    1_
$a Lišková, Barbora $u Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic.
700    1_
$a Anzenbacher, Pavel $u Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic. $7 xx0034447
700    1_
$a Skálová, Lenka $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic.
773    0_
$w MED00005725 $t European journal of nutrition $x 1436-6215 $g Roč. 55, č. 1 (2016), s. 361-71
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25663641 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20180525110210 $b ABA008
999    __
$a ok $b bmc $g 1180342 $s 961769
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 55 $c 1 $d 361-71 $e 20150208 $i 1436-6215 $m European journal of nutrition $n Eur J Nutr $x MED00005725
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Možnosti archivace